Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Recap: Redhill Biopharma Q1 Earnings

 

Redhill Biopharma (NASDAQ:RDHL) reported its Q1 earnings results on Thursday, June 23, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Redhill Biopharma reported an EPS of $0.03.

Revenue was down $2.34 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.28 which was followed by a 12.72% increase in the share price the next day.

Here's a look at Redhill Biopharma's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.33 -0.21 -0.12 -0.34
EPS Actual -0.05 -0.50 -0.06 -0.05
Revenue Estimate 24.08M 24.52M 25.02M 22.70M
Revenue Actual 22.07M 21.61M 21.50M 20.57M

To track all earnings releases for Redhill Biopharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.